CD274 and non-small cell lung carcinoma: High expression of PD-L1 has been observed in several solid tumours and previous studies have demonstrated a statistically significant association of PD-L1 expression with response to PD-1/PD-L1 therapies in previously-treated patients with advanced NSCLC [79,80,81].